the flip side to all that is and one of the issues with having a caregiver derive the data..... its open to bias to a degree in that they are looking harder for things even though it may not be there. Not sure how they get around this from a trial/placebo control point of view to eliminate this bias. its also the reason the FDA wants co-endpoints.
the flip side to all that is and one of the issues with having a...
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.10 |
Change
-0.150(0.74%) |
Mkt cap ! $2.566B | |||
| Open | High | Low | Value | Volume |
| $20.40 | $20.50 | $19.88 | $4.961M | 246.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 277 | $20.09 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.15 | 2400 | 1 |
View Market Depth
| Last trade - 16.10pm 08/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$20.12 |
Change
-0.150 ( 0.58 %) |
||||
| Open | High | Low | Volume | ||
| $20.45 | $20.50 | $19.88 | 139634 | ||
| Last updated 15.59pm 08/05/2024 ? | |||||
| NEU (ASX) Chart |